{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [["ADIPOKINES", "AIRWAY REACTIVITY", "ASTHMA", "OBESITY"]], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "24115053", "DateCompleted": {"Year": "2014", "Month": "10", "Day": "20"}, "DateRevised": {"Year": "2014", "Month": "03", "Day": "04"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1002/jcb.24678"], "ArticleDate": [], "Journal": {"ISSN": "1097-4644", "JournalIssue": {"Volume": "115", "Issue": "3", "PubDate": {"Year": "2014", "Month": "Mar"}}, "Title": "Journal of cellular biochemistry", "ISOAbbreviation": "J Cell Biochem"}, "ArticleTitle": "The many faces of asthma in obesity.", "Pagination": {"StartPage": "421", "EndPage": "426", "MedlinePgn": "421-6"}, "Abstract": {"AbstractText": ["Obesity is a major risk factor for the development of asthma, and causes severe, uncontrolled disease that responds poorly to therapy. The obese state alters early onset allergic asthma, and leads to the development of a novel form of late onset asthma secondary to obesity. The presentation of early onset allergic asthma is altered through effects on immune function. Factors such as mechanical loading, effects of adipokines on airways, altered diet, insulin resistance and altered metabolism of nitric oxide likely all contribute to increased airway reactivity in obesity, causing late onset asthma in obesity. Obesity also alters responses to environmental factors such as ozone and particulate matter. Focused studies to understand the importance of these factors in the pathogenesis of airway disease in obesity will be essential to develop therapies to intervene in this new epidemic of airway disease."], "CopyrightInformation": "\u00a9 2013 Wiley Periodicals, Inc."}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, Fletcher Allen Health Care, University of Vermont, Given D209, 89 Beaumont Avenue, Burlington, Vermont, 05405."}], "Identifier": [], "LastName": "Sideleva", "ForeName": "O", "Initials": "O"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Dixon", "ForeName": "A E", "Initials": "AE"}], "GrantList": [{"GrantID": "P30 RR031158", "Acronym": "RR", "Agency": "NCRR NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Cell Biochem", "NlmUniqueID": "8205768", "ISSNLinking": "0730-2312"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Adipokines"}, {"RegistryNumber": "31C4KY9ESH", "NameOfSubstance": "Nitric Oxide"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": ["metabolism"], "DescriptorName": "Adipokines"}, {"QualifierName": [], "DescriptorName": "Age of Onset"}, {"QualifierName": ["complications", "pathology", "therapy"], "DescriptorName": "Asthma"}, {"QualifierName": [], "DescriptorName": "Diet"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["complications", "pathology"], "DescriptorName": "Hypersensitivity"}, {"QualifierName": ["genetics"], "DescriptorName": "Insulin Resistance"}, {"QualifierName": ["metabolism"], "DescriptorName": "Nitric Oxide"}, {"QualifierName": ["complications", "pathology", "therapy"], "DescriptorName": "Obesity"}, {"QualifierName": ["metabolism"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Risk Factors"}, {"QualifierName": [], "DescriptorName": "Weight Loss"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2013", "Month": "9", "Day": "10"}, {"Year": "2013", "Month": "9", "Day": "12"}, {"Year": "2013", "Month": "10", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2013", "Month": "10", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2014", "Month": "10", "Day": "21", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["24115053", "10.1002/jcb.24678"]}}], "PubmedBookArticle": []}